Interaction of injectable neurotropic drugs with the red cell membrane

Toxicology in Vitro

Volumn 28, Issue 7, 2014, Pages 1274-1279

  Reinhart, Walter H ^a   Lubszky, Szabina ^a   Thöny, Sandra ^b   Schulzki, Thomas ^c  

^a KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^b AO RESEARCH INSTITUTE   (Switzerland)

^c Division of Laboratory Medicine   (Switzerland)

Author keywords

Drugs; Echinocyte; Erythrocyte; Membrane; Stomatocyte

Indexed keywords

CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; NEUROTROPIC AGENT; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CENTRAL NERVOUS SYSTEM AGENTS; PIRACETAM;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; ECHINOCYTOSIS; ERYTHROCYTE DISORDER; ERYTHROCYTE MEMBRANE; ERYTHROCYTE SHAPE; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR MODEL; PLASMA OSMOLALITY; STOMATOCYTOSIS; ANALOGS AND DERIVATIVES; CYTOLOGY; DRUG EFFECTS; ERYTHROCYTE; INJECTION; METABOLISM; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

CENTRAL NERVOUS SYSTEM AGENTS; CHLORPROMAZINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; ERYTHROCYTES; HUMANS; INJECTIONS; MICROSCOPY, ELECTRON, SCANNING; NEUROTRANSMITTER AGENTS; PHENOBARBITAL; PHENYTOIN; PIRACETAM; VALPROIC ACID;

EID: 84904459098     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2014.06.008     Document Type: Article

References (47)

1. An X., Mohandas N. Disorders of red cell membrane. Brit. J. Haematol. 2008, 141:367-375.
2. Baerlocher G.M., Beer J.H., Owen G.Rh., et al. The antineoplastic drug 5-fluorouracil produces echinocytosis and affects blood rheology. Brit. J. Haematol. 1997, 99:426-432.
3. Bessis M. Red cell shapes: an illustrated classification and its rationale. Nouv. Rev. Franc. Hematol. 1972, 12:721-746.
4. Butikofer P., Brodbeck U., Ott P. Modulation of erythrocyte vesiculation by amphiphilic drugs. Biochim. Biophys. Acta 1987, 901:291-295.
5. Caldwell K.K., Harris R.A. Effects of anesthetic and anticonvulsant drugs on calcium-dependent efflux of potassium from human erythrocytes. Eur. J. Pharmacol. 1985, 107:119-125.
6. Contreras F.X., Sanchez-Magraner L., Alonso A., Goni M.M. Transbilayer (flip-flop) lipid motion and lipid scrambling in membranes. FEBS Lett. 2010, 584:1779-1786.
7. Curry S.H. Plasma protein binding of chlorpromazine. J. Phram. Pharmacol. 1970, 22:193-197.
8. Deuticke B. Transformation and restoration of biconcave shape of human erythrocytes induced by amphiphilic agents and change of ionic environment. Biochim. Biophys. Acta 1968, 163:494-500.
9. Elferink J.G. Fluorescence studies of membrane interactions of chlorpromazine and chlorimipramine. Biochem. Pharmacol. 1977, 15:511-515.
10. Ferrell J.E., Huestis W.H. Phosphoinositide metabolism and the morphology of human erythrocytes. J. Cell Biol. 1984, 98:1992-1998.
11. Fischler L., Meredith D.O., Reinhart W.H. Influence of a parenteral fish-oil preparation (Omegaven®) on erythrocyte morphology and blood viscosity. Clin. Hemorheol. Microcirc. 2003, 28:79-88.
12. Fujii T., Sarto T., Tamura A., Wakatsuki M., Kanaho Y. Shape changes of human erythrocytes induced by various amphipathic drugs acting on the membrane of the intact cell. Biochem. Pharmacol. 1979, 28:613-620.
13. Hansotia P., Mazza J.J., Gatlin P. Diphenylhydantoin and fragility of erythrocytes in normal subjects and in patients with hereditary spherocytic anemia. Am. J. Clin. Pathol. 1975, 64:75-79.
14. Hariton C., Jadot G., Mesdjian E., Mandel P. Diazepam: kinetic profiles in various brain areas, plasma and erythrocytes after chronic administration in the rat. Eur. J. Drug Metab. Pharmacokinet. 1985, 10:105-111.
15. Hiemke C., Härtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol. Ther. 2000, 85:11-85.
16. Isomaa B., Hägerstrand H., Paatero G. Shape transformation induced by amphiphiles in erythrocytes. Biochim. Biophys. Acta 1987, 899:93-103.
17. König S.A., Knolle J., Friedewald S., Koelfen W., Longin E., Lenz T., Hannak D. Effects of valproic acid, (carbamazepine), and phenobarbitone on the fatty acid composition of erythrocyte membranes in children. Epilepsia 2003, 44:708-711.
18. Lundbaek J.A. Lipid bilayer-mediated regulation of ion channel function by amphiphilic drugs. J. Gen. Physiol. 2008, 131:421-429.
19. Manrique-Moreno M., Suwalsky M., Villena F., et al. Effects of the nonsteroidal anti-inflammatory drug naproxen on human erythrocytes and on cell membrane molecular models. Biophys. Chem. 2010, 147:53-58.
20. Mark M., Walter R., Meredith D.O., et al. Commercial taxane formulations induce stomatocytosis and increase blood viscosity. Brit. J. Pharmacol. 2001, 134:1207-1214.
21. Meiselman H. Rheology of shape-transformed human red cells. Biorheology 1978, 15:225-237.
22. Mohandas N., Wyatt J., Mel S.F., Rossi M.E., Shohet S.B. Lipid translocation across the human erythrocyte membrane. J. Biol. Chem. 1982, 257:6537-6543.
23. Noble S., Benfield P. Citalopram. A review of its pharmacology, clinical efficacy and tolerability in the treatment of depression. CNS Drugs 1997, 8:410-431.
24. Ogawa K., Yumoto R., Hamada N., Nagai J., Takano M. Interaction of valproic acid and carbapenem antibiotics with multidrug resistance-associated proteins in rat erythrocyte membranes. Epilepsy Res. 2006, 71:76-87.
25. Olson J.M., Ciliax B.J., Mancini W.R., Young A.B. Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur. J. Pharmacol. 1988, 152:47-53.
26. Ozkara C., Dreifuss F.E., Apperson Hansen C. Changes in red blood cells with valproate therapy. Acta Neurol. Scand. 1993, 88:210-212.
27. Plenge-Tellechea F., Soler F., Fernandez-Belda F. Tricyclic antidepressants inhibit the Ca(2+)-dependent ATPase activity from plasma membrane. Arch. Biochem. Biophys. 1999, 370:119-125.
28. Quinn P.J. Plasma membrane phospholipid asymmetry. Subcell. Biochem. 2002, 36:39-60.
29. Reinhart W.H. Binding of cyclosporine by erythrocytes: influence on cell shape and deformability. Eur. J. Clin. Invest. 1993, 23:177-181.
30. Reinhart W.H. Peculiar red cell shapes: fahraeus lecture 2011. Clin. Hemorheol. Microcirc. 2011, 49:11-27.
31. Reinhart W.H., Chien S. Red cell rheology in stomatocyte-echinocyte transformation: roles of cell geometry and cell shape. Blood 1986, 67:1110-1118.
32. Reinhart W.H., Felix Ch. Influence of propofol on erythrocyte morphology, blood viscosity and platelet function. Clin. Hemorheol. Microcirc. 2003, 29:33-40.
33. Reinhart W.H., Rohner F. The effect of amiodarone on the erythrocyte shape and membrane properties. Clin. Sci. 1990, 79:387-391.
34. Reinhart W.H., Baerlocher G.M., Cerny T., et al. Ifosfamide-induced stomatocytosis and mesna-induced echinocytosis: influence on biorheological properties of blood. Eur. J. Haematol. 1999, 62:223-230.
35. Reinhart W.H., Pleisch B., Harris L.G., et al. Influence of contrast media (iopromide, ioxaglate, gadolinium-DOTA) on blood viscosity, erythrocyte morphology and platelet function. Clin. Hemorheol. Microcirc. 2005, 32:227-239.
36. Schreier S., Malheiros S.V.P., de Paula E. Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects. Biochim. Biophys. Acta 2000, 1508:210-234.
37. Schrier S.L., Zachowski A., Devaux P.F. Mechanisms of amphipathic-induced stomatocytosis in human erythrocytes. Blood 1992, 79:782-786.
38. Sheetz M.P., Singer S.J. Biological membranes a bilayer couples. A molecular mechanism of drug-erythrocyte interactions. Proc. Natl. Acad. Sci. USA 1974, 71:4457-4461.
39. Suwalsky M., Hernàndez P., Villena F., et al. The anticancer drug chlorambucil interacts with the human erythrocyte membrane and model phospholipid bilayers. Z. Naturforsch. C 1999, 54:1089-1095.
40. Suwalsky M., Hernàndez P., Villena F., et al. The anticancer drug cisplatin interacts with the human erythrocyte membrane. Z. Naturforsch. C 2000, 55:461-466.
41. Suwalsky M., Mennickent S., Norris B., et al. The antiepileptic drug diphenylhydantoin affects the structure of the human erythrocyte membrane. Z. Naturforsch. C 2004, 59:427-431.
42. Suwalsky M., Mennickent S., Norris B., et al. Effects of the antiepileptic drug carbamazepine on human erythrocytes. Toxicol. In Vitro 2006, 20:1363-1369.
43. Tamai H., Wakamiya E., Mino M., Iwakoshi M. Alpha-tocopherol and fatty acid levels in red blood cells in patients treated with antiepileptic drugs. J. Nutr. Sci. Vitaminol. (Tokyo) 1988, 34:627-631.
44. Tamura A., Kawase F., Sato T., Fujii T. Binding of chlorpromazine, phenytoin and aspirin to the erythrocytes and lipoproteins in whole human blood. J. Pharmacol. 1987, 39:740-742.
45. Usman M., Khan A., Siddiq M. Thermodynamic properties of amphiphilic antidepressant drug citalopram HBr. J. Chem. Soc. Pak. 2010, 32:1-6.
46. Von Winckelmann S.L., Spriet I., Willems L. Therapeutic drug monitoring of phenytoin in critically ill patients. Pharmacotherapy 2008, 28:1391-1400.
47. Wong H.Y., Chu T.S., Lai J.C., Fung K.P., Fok T.F., Fujii T., Ho Y.Y. Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro. J. Cell. Biochem. 2005, 96:775-785.